Permanent Cardiac Pacemaker Implant with CC DRG Reimbursement

DRG 243 pertains to inpatient admissions for permanent cardiac pacemaker implantation with a Complication or Comorbidity, encompassing procedures for device placement in patients with added clinical complexity. This matters for inpatient reimbursement because the Diagnosis-Related Group assignment determines Medicare payment relative to case severity and resource consumption.

DRG 243 Overview

DRG 243 covers inpatient admissions for permanent cardiac pacemaker implantation with a Complication or Comorbidity. This Diagnosis-Related Group captures cases where patients require device placement and have additional clinical complexity that affects resource use. It matters for Centers for Medicare & Medicaid Services payment because the presence of a Complication or Comorbidity influences the payment weight and hospital reimbursement for the inpatient stay. Accurate assignment ensures alignment of clinical care intensity with Medicare inpatient payment.

DRG 243 Overview

Perioperative and device-implantation technique trials examining strategies to reduce acute procedural complications such as lead dislodgement, pocket hematoma, infection, and perioperative bradyarrhythmia. These studies typically enroll patients admitted for permanent pacemaker implantation with significant comorbidities (for example advanced age, anticoagulation, or heart failure) to compare surgical approaches, anesthesia regimens, or perioperative management bundles. Results directly inform inpatient protocols that can shorten length of stay, reduce readmissions and complication-related resource use, and are therefore highly relevant to hospital managers and payers focused on episode costs and quality metrics.
Comparative effectiveness research comparing different pacemaker systems or lead types and programming strategies for patients requiring implantation for symptomatic bradycardia or complete heart block. Trials or observational registries evaluate outcomes such as pacing thresholds, battery longevity, lead revision rates, and need for cardiac resynchronization in subgroups like patients with reduced ejection fraction or chronic atrial fibrillation. Findings help clinicians select devices and programming that optimize long-term performance and minimize future inpatient procedures and costs, making this important for both clinical decision-making and reimbursement planning.
Post-discharge outcomes and care coordination studies that follow patients after implantation to assess rates of device-related infection, late lead malfunction, quality of life, and healthcare utilization including emergency visits and rehospitalizations. These prospective cohort studies often target high-risk populations discharged after implantation (for example those with multiple comorbidities or social determinants that impede follow-up) to evaluate remote monitoring, nurse-led follow-up, or antimicrobial and wound-care pathways. Evidence from these studies supports interventions that reduce downstream inpatient utilization and readmission penalties, informing payer policies and bundled-payment models.

Perioperative and device-implantation technique trials examining strategies to reduce acute procedural complications such as lead dislodgement, pocket hematoma, infection, and perioperative bradyarrhythmia. These studies typically enroll patients admitted for permanent pacemaker implantation with significant comorbidities (for example advanced age, anticoagulation, or heart failure) to compare surgical approaches, anesthesia regimens, or perioperative management bundles. Results directly inform inpatient protocols that can shorten length of stay, reduce readmissions and complication-related resource use, and are therefore highly relevant to hospital managers and payers focused on episode costs and quality metrics.
Comparative effectiveness research comparing different pacemaker systems or lead types and programming strategies for patients requiring implantation for symptomatic bradycardia or complete heart block. Trials or observational registries evaluate outcomes such as pacing thresholds, battery longevity, lead revision rates, and need for cardiac resynchronization in subgroups like patients with reduced ejection fraction or chronic atrial fibrillation. Findings help clinicians select devices and programming that optimize long-term performance and minimize future inpatient procedures and costs, making this important for both clinical decision-making and reimbursement planning.
Post-discharge outcomes and care coordination studies that follow patients after implantation to assess rates of device-related infection, late lead malfunction, quality of life, and healthcare utilization including emergency visits and rehospitalizations. These prospective cohort studies often target high-risk populations discharged after implantation (for example those with multiple comorbidities or social determinants that impede follow-up) to evaluate remote monitoring, nurse-led follow-up, or antimicrobial and wound-care pathways. Evidence from these studies supports interventions that reduce downstream inpatient utilization and readmission penalties, informing payer policies and bundled-payment models.

OpenPayer

Permanent Cardiac Pacemaker Implant with CC: Inpatient Reimbursement Overview

Sign up for drg 243 policy alerts

DRG 243 Overview

OpenPayer

Permanent Cardiac Pacemaker Implant with CC: Inpatient Reimbursement Overview

Sign up for drg 243 policy alerts

DRG 243 Overview

Clinical Trials

Related Codes

References

Clinical Trials

Related Codes

References